Who has invested in Parse Biosciences?

Soleus Capital, Marshall Wace, Bioeconomy Capital are named among the investors backing Parse Biosciences.

Parse Biosciences Funding: $50M Raised, Series C (2022)

Parse Biosciences funding overview

Parse Biosciences is based in Seattle. Parse Biosciences has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in January 2022. The round record for Parse Biosciences runs through 2022; nothing later has been disclosed. Investors on record include Soleus Capital, Marshall Wace, Bioeconomy Capital. 3 distinct backers are named across the disclosed rounds.

Parse Biosciences at a glance

Total raised: $50M
Latest round: Series C
Latest round date: January 2022
Headquarters: Seattle
Notable investors: Soleus Capital, Marshall Wace, Bioeconomy Capital

Frequently asked about Parse Biosciences funding

How much has Parse Biosciences raised?: Parse Biosciences has raised $50M in total disclosed funding across the rounds on record.
Who has invested in Parse Biosciences?: Soleus Capital, Marshall Wace, Bioeconomy Capital are named among the investors backing Parse Biosciences.
What was the latest Parse Biosciences funding round?: The most recent disclosed round is a Series C, announced in January 2022.
Where is Parse Biosciences based?: Parse Biosciences is based in Seattle.
When did Parse Biosciences last raise?: The last disclosed Parse Biosciences round closed in January 2022 at Series C.

Every Parse Biosciences figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Seattle at a similar stage.

Parse Biosciences Funding: $50M Raised, Series C (2022)

Parse Biosciences funding overview

Parse Biosciences at a glance

Frequently asked about Parse Biosciences funding

Companies related to Parse Biosciences (30)

Browse related funding lists (7)